clexane multi injizierbare lösung
sanofi-aventis (suisse) sa - enoxaparinum natricum - injizierbare lösung - enoxaparinum natricum 300 mg corresp. 30000 u.i., conserv.: alcohol benzylicus 45 mg, aqua ad iniectabile q.s. ad solutionem pro 3 ml. - gerinnungshemmer - biotechnologika
allopurinol hexal 300
h e x a l aktiengesellschaft (3079284) - allopurinol - tablette - teil 1 - tablette; allopurinol (03633) 300 milligramm
aclinda 150
sandoz pharmaceuticals gmbh (3060764) - clindamycinhydrochlorid - kapsel - teil 1 - kapsel; clindamycinhydrochlorid (03812) 162,86 milligramm
elevit plus filmtabletten
bayer austria gmbh - eisen(ii)-fumarat; kaliumiodid; pyridoxin hydrochlorid; calciumhydrogenphosphat; biotin; retinolpalmitat; thiamin nitrat; dinatriumselenit wasserfrei; folsÄure; nicotinamid; mangansulfat monohydrat; calcium pantothenat; cyanocobalamin; magnesiumoxid; ascorbinsÄure; riboflavin; kupfersulfat; calcium 5-methyltetrahydrofolat; colecalciferol; zinkcitrat trihydrat; alpha-tocopherolacetat -
vaprino 100 mg hartkapseln
sanofi-aventis gmbh - racecadotril -
posaconazol sandoz 40mg/ml - suspension zum einnehmen
sandoz gmbh - posaconazol -
posaconazol altan 300 mg konzentrat zur herstellung einer infusionslösung
altan pharma ltd - posaconazol -
oxbryta
pfizer europe ma eeig - voxelotor - anemia; anemia, hemolytic; anemia, sickle cell - other hematological agents - oxbryta is indicated for the treatment of haemolytic anaemia due to sickle cell disease (scd) in adults and paediatric patients 12 years of age and older as monotherapy or in combination with hydroxycarbamide.
pyrukynd
agios netherlands b.v. - mitapivat sulfate - genetic diseases, inborn; anemia, hemolytic - other hematological agents - pyrukynd is indicated for the treatment of pyruvate kinase deficiency (pk deficiency) in adult patients (see section 4.
yimmugo 100 mg/ml
biotest pharma gmbh (3194861) - infusionslösung - 100 mg/ml